Superworth

QuidelOrtho profit margin QDEL

Gross, operating and net profit as a share of revenue over the last twelve months, from 2022.

Net margin, 12 months
−39.2%
Operating margin, 12 months
−30.8%
Net margin on a year earlier
−22.2 pts
Peer median
14.2%

Over the twelve months to Jun 28, 2026, QuidelOrtho kept −39.2% of its revenue as net profit, with an operating margin of −30.8% and a gross margin of 44.6%.

The median for 6 diagnostics and research stocks of a similar size is 14.2%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−41.5%−33.7%46.7%
FY2024−73.7%−70.5%46.2%
FY2023−0.3%4.6%49.9%
FY202216.8%25.8%59.3%
FY202141.5%53.3%75.3%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−39.2%−22.2 pts−30.8%
Q1 FY26−45.6%−32.6 pts−37.0%
Q4 FY25−41.5%+32.3 pts−33.7%
Q3 FY25−43.5%+22.8 pts−35.1%
Q2 FY25−17.0%+48.6 pts−8.5%
Q1 FY25−13.0%+48.7 pts−6.2%
Q4 FY24−73.7%−73.4 pts−70.5%
Q3 FY24−66.2%−66.7 pts−64.6%
Q2 FY24−65.6%−67.0 pts−63.8%
Q1 FY24−61.7%−65.4 pts−60.0%
Q4 FY23−0.3%−17.1 pts4.6%
Q3 FY230.4%−26.2 pts5.9%

Against its peers

Companies in Medical - Diagnostics & Research nearest QuidelOrtho's size, closest first, today.

CompanyProfit margin
QDELQuidelOrtho−39.2%
NRCNRC Health4.2%
CDNACareDx24.2%
VCYTVeracyte20.4%
BLLNBillionToOne9.5%
LNTHLantheus17.7%
CAICaris Life Sciences10.6%
Peer median14.2%

Where QuidelOrtho ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on QuidelOrtho

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.